Yulong Zheng

机构：Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, First Affiliated Hospital Zhejiang University, Ocean University of China · ORCID：0000-0002-1401-9883

发表论文 39 篇 · 总被引 847 次 · h-index 17

代表论文

• MiR-484 promotes non-small-cell lung cancer (NSCLC) progression through inhibiting Apaf-1 associated with the suppression of apoptosis (2017 · Biomedicine & Pharmacotherapy · 被引 68)
• HIF-1α promoted vasculogenic mimicry formation in lung adenocarcinoma through NRP1 upregulation in the hypoxic tumor microenvironment (2021 · Cell Death and Disease · 被引 63)
• A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells (2020 · Frontiers in Oncology · 被引 53)
• Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer (2019 · International Journal of Oncology · 被引 38)
• The regulation of Neuropilin 1 expression by miR‐338‐3p promotes non‐small cell lung cancer via changes in EGFR signaling (2019 · Molecular Carcinogenesis · 被引 34)
• Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial (2021 · 癌症：英文版 · 被引 25)